Additional information
| Active substance | Citicoline |
|---|---|
| Chemical name | Cytidine diphosphate-choline (CDP-Choline) |
| Side effects | Generally well tolerated, but may include insomnia, headache, diarrhea, nausea, and blurred vision |
| Effects | Improves memory and cognitive function, enhances communication between neurons, increases energy levels in the brain |
| Dosage (sports) | 250-500 mg per day |
| Dosage (medical) | Commonly 500-2000 mg per day in divided doses |
| Half-life | Approximately 56 hours |
| Main action | Enhances cognitive function and increases phospholipid synthesis |
| Substance class | Nootropic |
| Formula | C14H26N4O11P2 |
| Storage conditions | Store at room temperature away from moisture and heat |
| Trade name | Cognizin, NeurAxon, Somazina, among others |
| Blood pressure | Unlikely to affect blood pressure significantly |
| Also known as | CDP-Choline, Citicholine |
| Strength | 500mg |
| Lab Test | Not typically required for monitoring |
| Hepatotoxicity | No known hepatotoxic effects |
| Water Retention | Minimal or no effect |
| Use in sports | Used to enhance mental focus and cognitive capabilities |
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Packing | 10 tabs/blister |
Reviews
There are no reviews yet.